All Biotech companies at once!

Project information panel

3GB-TEST – Introducing diagnostic applications of ?3Gb-testing? in human genetics

The landscape of genetic testing is rapidly changing. Soon, whole genome sequence analysis (3Gb-testing) will be an effective and financially viable alternative to targeted gene analysis. New technologies that allow efficient sequencing of a whole human genome in a diagnostic setting will have an enormous impact on diagnostic centres replacing many existing molecular and cytogenetic tests. Patients deserve to benefit from our vastly growing knowledge on functional genomics. 3Gb-testing is the ideal method to bring these benefits to the public. However, it is critical to avoid mistakes with respect to ethics, quality, over or mis-interpretation of data. It is essential that our society is prepared for the change once it is implemented. Hence, current gaps in our knowledge have to be identified and research has to be initiated to bridge these gaps. The 3Gb-TEST project will bring stakeholders together and ensure they are informed with respect to the desirable and undesirable developments. The clinical utility and cost effectiveness of whole genome sequencing needs to be determined as part of a robust health technology assessment process (HTA). Interpretation of sequence data in terms of clinical relevance will pose a challenge to both laboratory and clinical geneticists. Substantial investments may be required and the logistic restructuring of genetic services will need to be addressed. This project aims to prepare Europe for innovations in molecular testing. Quality assessment schemes, HTA and guidelines have to be in place. Healthcare professionals must be aware of the impending change and potential impact on practice. The Consortium will inform the healthcare community and make recommendations to the European Commission, the European Society of Human Genetics, and national organizations relevant to this field. A key output will be a validated roadmap for the implementation of diagnostic genome sequencing in Europe.

  •  2013-09-01  2015-08-31
  • FP7-HEALTH / HEALTH.2013.4.1-4 / FP7-HEALTH-2013-INNOVATION-1
  • Overall Cost: 0.55 M.Eur
  •   > Cartagenia
      > ServiceXS
  • Other project partners
  • Preparing the future for health research and innovation 
  • Life Sciences 
  • FP7 Data provision: © European Union; Source: CORDIS, Cordis | This page is not provided by the European Commission 

 research   Development   Laboratory   healthcare   services   RNA   diagnostic   Analysis   genomics   Innovation   sequencing   Health   europe   technology   testing   gene   Labor   Service   clinical   lab   molecular   quality   Genetics   technologie   search   Patient   Gen   human   genomic   process   data   API   genetic   Patients   omic   develop   EPA   CARE   genome   sequence   healthcare co   healthcare professionals   testin   genetic testing   needs   take   technologies   map   CHANGING   dsc   heme   target   professionals   functional genomics   project   genom   Whole genome Sequencing   European   alternative   sequence analysis   research   Development   Laboratory   healthcare   services   RNA   diagnostic   Analysis   genomics   Innovation   sequencing   Health   europe   research   Development   Laboratory   healthcare   services   RNA   diagnostic   Analysis   genomics   Innovation   sequencing   Health   europe   technology   testing   gene   Labor   Service   clinical   lab   molecular   quality   Genetics   technologie   search   Patient   Gen   human   genomic   process   data   API   genetic   Patients   omic   develop   EPA   CARE   genome   sequence   healthcare co   healthcare professionals   testin   genetic testing   needs   take   technologies   map   CHANGING   dsc   heme   target   professionals   functional genomics   project   genom   Whole genome Sequencing   European   alternative   sequence analysis 

comments powered by Disqus

Report an error:

Did you noticed an error? Please report here...


Top Countries

 DE 933
 UK 761
 NL 663
 IT 616
 FR 516
 BE 315
 ES 306
 CH 305
 SE 237
 AT 179

Top Business Area

 RED 3030
 WHI 1096
 SEL 643
 GRE 489
 CON 311
 ANA 285
 DNA 158
 INF 144
 JOB 36

EU-Projects Champions

 Acreo 41
 Johnson 37
 DSM 32
 Biotec 30
 Tecna 28

Top Legal Types

 LTD 2381
 PLC 1071